FDAnews
www.fdanews.com/articles/120896-wyeth-obtains-eu-positive-opinion-for-pneumococcal-conjugate-vaccine

Wyeth Obtains EU Positive Opinion for Pneumococcal Conjugate Vaccine

September 30, 2009
Wyeth Pharmaceuticals, a division of Wyeth, has reported that the European Medicines Agency’s Committee for Medicinal Products for Human Use or CHMP has issued a positive opinion for the company’s pneumococcal conjugate vaccine, Prevenar 13.
TradingMarkets